In addition, ADAR1 can further aggravate the progression of pulmonary arterial hypertension by mediating the m1A modification of circCDK17 and subsequently triggering the proliferation of pulmonary artery smooth muscle cells (Zhang et al., 2023). Here, ADAR is linked to pulmonary arterial hypertension.